Lead party: Ohara Pharmaceutical Co., Ltd., AAIC Investment Pte. Ltd. (lead investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: Revital Healthcare (EPZ) Limited (private company) · Sector: Healthcare, Medical Supplies · Countries of operation: Kenya
Transaction type: Investment · Asset class: Private Equity · Strategy: Growth Equity · Instrument: Equity · Fund: Africa Healthcare Fund I (AHF1)
Lead investor/buyer: Ohara Pharmaceutical Co., Ltd., AAIC Investment Pte. Ltd. · Investors/buyers: Ohara Pharmaceutical Co., Ltd., AAIC Investment Pte. Ltd.
Legal advisers: not identified in the source record.
Source: announced 27 December 2021. Original announcement: aa-ic.com.


